DoesBCR/ABL1positive Acute Myeloid Leukaemia Exist?-Reference-Cited by-同舟云学术

DoesBCR/ABL1positive Acute Myeloid Leukaemia Exist?

Published:2013-03-25 Issue:4 Volume:161 Page:541-550
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Nacheva Ellie P.¹,Grace Colin D.¹,Brazma Diana²,Gancheva Katya¹,Howard-Reeves Julie²,Rai Lena¹,Gale Rosemary E.³,Linch David C.³,Hills Robert K.⁴,Russell Nigel⁵,Burnett Alan K.⁴,Kottaridis Panagiotis D.²

Affiliation:

1. UCL Med School; Royal Free Campus; London UK

2. Department of Haematology; Royal Free NHS Trust; London UK

3. UCL Cancer Institute; London UK

4. Department of Haematology; University of Cardiff; Cardiff UK

5. Department of Haematology; University of Nottingham; Nottingham UK

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12301/fullpdf

Reference24 articles.

1. Genome Profile Of Ph Positive ALL In Adult Patients;Chanalaris;Haematologica, 13th Congress of the European Hematology Association,2008

2. Genome profiling of normal karyotype AML with high density array comparative genome hybridization;Chanalaris;Haematologica, 14th Congress of the European Hematology Association,2009

3. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study;Den Boer;The Lancet Oncology,2009

4. Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells;Feldhahn;The Journal of Experimental Medicine,2007

5. Structural variation in the human genome;Feuk;Nature Reviews Genetics,2006

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study;Blood Cancer Journal;2024-05-31

2. Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics;International Journal of Molecular Sciences;2024-04-11

3. Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study.;2024-04-09

4. The impact of the BCR-ABL oncogene in the pathology and treatment of chronic myeloid leukemia;Pathology - Research and Practice;2024-02

5. Epigenomic machinery regulating pediatric AML: Clonal expansion mechanisms, therapies, and future perspectives;Seminars in Cancer Biology;2023-07